Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 33


EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.

Caudron A, Battistella M, Feugeas JP, Pages C, Basset-Seguin N, Mazouz Dorval S, Funck Brentano E, Sadoux A, Podgorniak MP, Menashi S, Janin A, Lebbé C, Mourah S.

Exp Dermatol. 2016 Aug;25(8):618-22. doi: 10.1111/exd.13022. Epub 2016 May 20.


Validation of a preclinical model for assessment of drug efficacy in melanoma.

Delyon J, Varna M, Feugeas JP, Sadoux A, Yahiaoui S, Podgorniak MP, Leclert G, Dorval SM, Dumaz N, Janin A, Mourah S, Lebbé C.

Oncotarget. 2016 Mar 15;7(11):13069-81. doi: 10.18632/oncotarget.7541.


EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF.

Khayati F, Pérez-Cano L, Maouche K, Sadoux A, Boutalbi Z, Podgorniak MP, Maskos U, Setterblad N, Janin A, Calvo F, Lebbé C, Menashi S, Fernandez-Recio J, Mourah S.

Oncotarget. 2015;6(12):9766-80.


EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells.

Delyon J, Khayati F, Djaafri I, Podgorniak MP, Sadoux A, Setterblad N, Boutalbi Z, Maouche K, Maskos U, Menashi S, Lebbé C, Mourah S.

Exp Dermatol. 2015 Jun;24(6):443-8. doi: 10.1111/exd.12693. Epub 2015 Apr 16.


A novel tumor suppressor function of Kindlin-3 in solid cancer.

Djaafri I, Khayati F, Menashi S, Tost J, Podgorniak MP, Sadoux A, Daunay A, Teixeira L, Soulier J, Idbaih A, Setterblad N, Fauvel F, Calvo F, Janin A, Lebbé C, Mourah S.

Oncotarget. 2014 Oct 15;5(19):8970-85.


Driver KIT mutations in melanoma cluster in four hotspots.

Dumaz N, André J, Sadoux A, Laugier F, Podgorniak MP, Mourah S, Lebbé C.

Melanoma Res. 2015 Feb;25(1):88-90. doi: 10.1097/CMR.0000000000000116.


BRAF(V600) mutation levels predict response to vemurafenib in metastatic melanoma.

Lebbé C, How-Kit A, Battistella M, Sadoux A, Podgorniak MP, Sidina I, Pages C, Roux J, Porcher R, Tost J, Mourah S.

Melanoma Res. 2014 Aug;24(4):415-8. doi: 10.1097/CMR.0000000000000088. No abstract available.


EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.

Lescaille G, Menashi S, Cavelier-Balloy B, Khayati F, Quemener C, Podgorniak MP, Naïmi B, Calvo F, Lebbe C, Mourah S.

BMC Cancer. 2012 Mar 23;12:115. doi: 10.1186/1471-2407-12-115.


A reliable method for the selection of exploitable melanoma archival paraffin embedded tissues for transcript biomarker profiling.

Lebbe C, Guedj M, Basset-Seguin N, Podgorniak MP, Menashi S, Janin A, Mourah S.

PLoS One. 2012;7(1):e29143. doi: 10.1371/journal.pone.0029143. Epub 2012 Jan 17.


Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype.

Abdelkarim M, Vintonenko N, Starzec A, Robles A, Aubert J, Martin ML, Mourah S, Podgorniak MP, Rodrigues-Ferreira S, Nahmias C, Couraud PO, Doliger C, Sainte-Catherine O, Peyri N, Chen L, Mariau J, Etienne M, Perret GY, Crepin M, Poyet JL, Khatib AM, Di Benedetto M.

PLoS One. 2011;6(8):e23334. doi: 10.1371/journal.pone.0023334. Epub 2011 Aug 15.


EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2.

Bougatef F, Menashi S, Khayati F, Naïmi B, Porcher R, Podgorniak MP, Millot G, Janin A, Calvo F, Lebbé C, Mourah S.

PLoS One. 2010 Aug 31;5(8):e12265. doi: 10.1371/journal.pone.0012265.


Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma.

Paule B, Deslandes E, Le Mouel SP, Bastien L, Podgorniak MP, Allory Y, de la Taille A, Menashi S, Calvo F, Mourah S.

Int J Biol Markers. 2010 Apr-Jun;25(2):112-5.


Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas.

Paule B, Bastien L, Deslandes E, Cussenot O, Podgorniak MP, Allory Y, Naïmi B, Porcher R, de La Taille A, Menashi S, Calvo F, Mourah S.

PLoS One. 2010 May 19;5(5):e10715. doi: 10.1371/journal.pone.0010715.


Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.

Lalou C, Scamuffa N, Mourah S, Plassa F, Podgorniak MP, Soufir N, Dumaz N, Calvo F, Basset-Seguin N, Khatib AM.

PLoS One. 2010 Apr 9;5(4):e9992. doi: 10.1371/journal.pone.0009992.


Distinct expression patterns of the E3 ligase SIAH-1 and its partner Kid/KIF22 in normal tissues and in the breast tumoral processes.

Bruzzoni-Giovanelli H, Fernandez P, Veiga L, Podgorniak MP, Powell DJ, Candeias MM, Mourah S, Calvo F, Marín M.

J Exp Clin Cancer Res. 2010 Feb 9;29:10. doi: 10.1186/1756-9966-29-10.


Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.

Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.

Arch Dermatol. 2009 Oct;145(10):1105-13. doi: 10.1001/archdermatol.2009.209.


EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2.

Bougatef F, Quemener C, Kellouche S, Naïmi B, Podgorniak MP, Millot G, Gabison EE, Calvo F, Dosquet C, Lebbé C, Menashi S, Mourah S.

Blood. 2009 Dec 24;114(27):5547-56. doi: 10.1182/blood-2009-04-217380. Epub 2009 Oct 16.


Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia.

Mourah S, Porcher R, Lescaille G, Rousselot P, Podgorniak MP, Labarchède G, Naimi B, Medioni J, Dombret H, Calvo F.

Int J Biol Markers. 2009 Jan-Mar;24(1):22-31.


Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.

Quemener C, Gabison EE, Naïmi B, Lescaille G, Bougatef F, Podgorniak MP, Labarchède G, Lebbé C, Calvo F, Menashi S, Mourah S.

Cancer Res. 2007 Jan 1;67(1):9-15.


Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation.

Kellouche S, Mourah S, Bonnefoy A, Schoëvaert D, Podgorniak MP, Calvo F, Hoylaerts MF, Legrand C, Dosquet C.

Exp Cell Res. 2007 Feb 1;313(3):486-99. Epub 2006 Oct 28.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk